BEST data for your products

“If you can’t measure it, you can’t improve it!”
— Peter's Rule #26

What is BEST:

  • Biomaterials Enhanced Simulation Testing (BEST) comprises several patented techniques of tailored and integrated analysis of a material, tissue, device - even an injectable hydrogel for 3D bioprinting or a drug-release material - under conditions which are more relevant for the target application.

  • It gives you proper quantified data of the properties of your sample or material which can be used to optimize the material and even predict how it would behave under expected circumstances.

  • We can use both pro- and retrospective data and assist you in making or optimizing SOP

  • With the right data you can implement a predictive analysis and a risk assessment, including contribution to your QMS portfolio.

What are BEST values:

Reality data • Higher clinical relevancy • Less costs • Shorter lead time • Required by Regulations • Higher ethical value (3R) • Faster to market • Higher reliability

How to get these:

1. SET UP

Define proper and relevant conditions for your application

2. MAKE IT

Stimulate and get specimen properties in time, phase and space domains

3. GET DATA

Extract key time-invariant properties with idempotent analysis

4. REACH GOALS

Optimize solutions for yours application needs.

“It is a capital mistake to theorize before one has data”
— Sherlock Holmes

Therefore BEST gets the data analysis before the theory

BEST evidences

“The BEST method has given us valuable data which we would not be able to get otherwise.”
— Dr. Anne-Marie Haaparanta, CTO, Askel Healthcare Ltd.

Seqvera Ltd. is proud to announce its participation in the LIFESAVER project.

It addresses the current unmet needs in creating a valid scientific knowledge base for the development and implementation of regulatory approaches relevant to maternal and fetal health.

It aims to generate and validate the effects data of environmental pollutants and pharma treatments for pregnant women, usually impossible to assess otherwise. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101036702.

Green Deal Challenge

Towards better health

CArdiovascular REsolution of INflammation to promote HEALTH (CARE-IN-HEALTH), responds to an unmet medical need by addressing one of the critical hallmarks of the phenotypic and functional cardiovascular during the transition from health to Cardiovascular disease (CVD): Chronic Inflammation.

This project has received funding from the European Union in the Horizon Europe program under Grant Agreement No 101095413.

Peer-reviewed publications, presentations and public activities

  • New US patent-pending application presents a model-free method for determination of the drug transport signature (DTS) with the BEST approach

  • BEST injectability optimization for pain management was featured at EORS-2023 conference in Porto

  • Application of BEST for testing scaffolds for bone tissue engineering at ICORS 2022 World Congress

  • Featuring BEST achievements on TERMIS 2021 World Congress

  • BEST improvement of the dental ceramics integration with soft tissues

  • Recent publication on compliance of scaffolds for articular cartilage repair

  • COST CA17116 “SPRINT” for research, regulative and translational work of perinatal derivatives as tissue engineering products

  • BEST has demonstrated benefits in veterinary practice (European Biomaterials Society congress 2017, Athens) for articular cartilage regeneration

See more details at BEST Cases